Clinical Trial: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2
Brief Summary: The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers
Detailed Summary: not available at this time
Sponsor: University of Colorado, Denver
Current Primary Outcome:
- Subjective dose estimate
- Observed withdrawal rating
- Opioid antagonist rating
- Pupil diameter
- Analog rating scale for drug effects
- Drug effect characteristics
- Drug/Money Preferences
Original Primary Outcome:
- Analog rating scale for drug effects
- Drug effect characteristics
- Drug/Money Preferences
- Subjective dose estimate
- Observed withdrawal rating
- Opioid antagonist rating
- Pupil diameter
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Colorado, Denver
Dates:
Date Received: September 20, 1999
Date Started: October 1999
Date Completion:
Last Updated: May 2, 2017
Last Verified: May 2017